pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Phase 3
pipamperone dihydrochloride
pipamperone dihydrochloride
Major Depressive Disorder
AneuroTech
Marketed
piperacillin sodium
Piperacillin (piperacillin sodium)
Bacterial Respiratory Tract Infections
Istituto Biochimico Italiano Giovanni Lorenzini Spa
Preclinical
piperlongumine
piperlongumine
Recurrent Glioblastoma Multiforme (GBM)
TargTex SA
← prev
page 207 of 231
next →
Pain
89
Neurology
1
Preclinical
pirlindole
pirlindole [INN]
Multiple Sclerosis
Biovista Inc
Phase 2
pirmitegravir
pirmitegravir [INN]
Human Immunodeficiency Virus (HIV) Infections (AIDS)
ST Pharm Co Ltd
Marketed
piroxicam
Piroxicam
Osteoarthritis Pain
Nostrum Pharmaceuticals LLC
Marketed
pirtobrutinib
Jaypirca (pirtobrutinib)
Chronic Lymphocytic Leukemia (CLL)
Eli Lilly and Co
Marketed
pit viper snake [Crotalidae] (polyvalent) immunoglobulin F(ab')2 antivenom [equine]
Anavip
Poisoning
Rare Disease Therapeutics Inc
Phase 3
pitolisant GR
pitolisant [INN]
Narcolepsy
$HRMY
Harmony Biosciences Holdings, Inc.
pre_registration
pivekimab sunirine
pivekimab sunirine
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
$ABBV
AbbVie Inc.
Phase 3
pivodisgene parvec
pivodisgene parvec [INN]
Duchenne Muscular Dystrophy
$RGNX
REGENXBIO Inc.
Marketed
plasma protein fraction (human)
Plasmanate
Hemorrhagic Shock
Grifols USA LLC
Marketed
plasminogen (human)
Ryplazim (plasminogen (human)-tvmh)
Congenital Plasminogen Deficiency
ProMetic BioTherapeutics Inc
Phase 3
plasminogen concentrate
Conjunctivitis
Kedrion SpA
Phase 3
plastoquinone decyl triphenylphosphonium bromide
Visomitin
Keratoconjunctivitis Sicca (Dry Eye)
Mitotech SA
Marketed
plazomicin sulfate
Zemdri (plazomicin sulfate)
Pyelonephritis
Cipla USA Inc
Marketed
plecanatide
Trulance (plecanatide)
Constipation
Salix Pharmaceuticals Ltd
Phase 2
plencifgene parvec
plencifgene parvec
Cystic Fibrosis
$FDMT
4D Molecular Therapeutics, Inc.
Phase 3
plinabulin
plinabulin
Febrile Neutropenia
$BYSI
BeyondSpring Inc.
Phase 2
plixorafenib
plixorafenib
Central Nervous System (CNS) Tumor
Fore Biotherapeutics Inc
Phase 2
plogosertib
plogosertib [INN]
Bladder Cancer
Tethra Biosciences Inc
Phase 3
pneumococcal conjugate (21-valent) vaccine
Pneumonia
SK Bioscience Ltd
pre_registration
pneumococcal polysaccharide [21-valent] vaccine
Capvaxive
Streptococcal Pneumonia
$MRK
Merck & Co., Inc.
Marketed
pneumococcal polysaccharide [23-valent] vaccine
Pneumovax 23
Streptococcal Pneumonia
$MRK
Merck & Co., Inc.
Marketed
pneumococcal polysaccharide [serotypes 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, 33F] (20-valent) vaccine
Prevnar 20
Otitis Media
$PFE
PFIZER INC
Preclinical
pneumococcal vaccine
Streptococcal Pneumonia
Aeolian Biotech LLC
Preclinical
pneumococcal vaccine 2
Streptococcal Pneumonia
Aeolian Biotech LLC
Phase 1
pneumonic plaque vaccine
Pneumonic Plague
Wake Forest University
Phase 2
pocenbrodib hydrochloride
pocenbrodib hydrochloride
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Pathos AI Inc
Phase 2
pociredir
pociredir
Sickle Cell Disease
$FULC
Fulcrum Therapeutics, Inc.
